Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yang, Le ^a   Han, Zhen ^a   Tian, Lei ^a   Mai, Ping ^a   Zhang, Yuanyuan ^a   Wang, Lin ^a   Li, Liying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; CHEMOKINE; CHROMONE DERIVATIVE; CYTOKINE; LYSOPHOSPHOLIPID; MORPHOLINE DERIVATIVE; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; RAC1 PROTEIN; RAC1 PROTEIN, MOUSE; S1PR1 PROTEIN, MOUSE; S1PR3 PROTEIN, RAT; SMALL INTERFERING RNA; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2, MOUSE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FIBROSIS; FLUORESCENCE MICROSCOPY; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MACROPHAGE; METABOLISM; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CHROMONES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FIBROSIS; LIVER; LYSOPHOSPHOLIPIDS; MACROPHAGES; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MORPHOLINES; NEUROPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PYRAZOLES; PYRIDINES; RAC1 GTP-BINDING PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOSPHINGOLIPID; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84940845431     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13423     Document Type: Article

References (43)

1. Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445-455 (2013).
2. Szabo, G., Mandrekar, P. & Dolganiuc, A. Innate immune response and hepatic inflammation. Semin Liver Dis 27, 339-350 (2007).
3. Klein, I. et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110, 4077-4085 (2007).
4. Marra, F., Aleffi, S., Galastri, S. & Provenzano, A. Mononuclear cells in liver fibrosis. Semin Immunopathol 31, 345-358 (2009).
5. Ramachandran, P. & Iredale, J. P. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol 56, 1417-1419 (2012).
6. Thomas, J. A. et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53, 2003-2015 (2011).
7. Pradere, J. P. et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58, 1461-1473 (2013).
8. Han, Z. et al. 15-deoxy-Delta(12,14)-prostaglandin J(2) reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. Hepatology 56, 350-360 (2012).
9. Chang, N., Xiu, L. & Li, L. Sphingosine 1-Phosphate Receptors Negatively Regulate Collagen Type I/III Expression in Human Bone Marrow-derived Mesenchymal Stem Cell. J Cell Biochem 115, 359-367 (2014).
10. Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu Rev Biochem 82, 637-662 (2013).
11. Orr, G. K. & Obeid, L. M. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim Biophys Acta 1831, 157-166 (2013).
12. Maceyka, M., Harikumar, K. B., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22, 50-60 (2012).
13. Liu, X. et al. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation. J Cell Physiol 226, 2370-2377 (2011).
14. Spiegel, S. & Milstien, S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11, 403-415 (2011).
15. Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 30, 69-94 (2012).
16. Jolly, P. S. et al. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med 199, 959-970 (2004).
17. Idzko, M. et al. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. Faseb J 16, 625-627 (2002).
18. Graeler, M. & Goetzl, E. J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. Faseb J 16, 1874-1878 (2002).
19. Qin, Q. et al. Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway. Cardiovasc Diabetol 12, 37 (2013).
20. Ridley, A. GTPase switch: Ras then Rho and Rac. Nat Cell Biol 15, 337 (2013).
21. Saxena, M. et al. The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration. Oncogene 34, 188-198 (2015).
22. Steffen, A. et al. Rac function is crucial for cell migration but is not required for spreading and focal adhesion formation. J Cell Sci 126, 4572-4588 (2013).
23. He, Y. et al. Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton. Mol Biol Cell 24, 3369-3380 (2013).
24. Yang, L. et al. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-beta1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. Am J Pathol 181, 85-97 (2012).
25. Olieslagers, S., Pardali, E., Tchaikovski, V., Ten, D. P. & Waltenberger, J. TGF-beta1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus. Cardiovasc Res 91, 510-518 (2011).
26. Hanna, S. & El-Sibai, M. Signaling networks of Rho GTPases in cell motility. Cell Signal 25, 1955-1961 (2013).
27. Higashiyama, R. et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 45, 213-222 (2007).
28. Kisseleva, T. & Brenner, D. A. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 56, 965-972 (2012).
29. Li, C. et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50, 1174-1183 (2009).
30. Li, C. et al. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol 175, 1464-1472 (2009).
31. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661 (2010).
32. Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838-851 (2008).
33. Friedman, S. L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275, 2247-2250 (2000).
34. Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4, 397-407 (2003).
35. Anliker, B. & Chun, J. Lysophospholipid G protein-coupled receptors. J Biol Chem 279, 20555-20558 (2004).
36. Salata, D., Budkowska, M. & Dolegowska, B. [Sphingosine-1-phosphate-molecular maestro]. Postepy Biochem 58, 281-291 (2012).
37. Weichand, B. et al. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. Eur J Immunol 43, 3306-3313 (2013).
38. Cheng, Q. et al. The S1P receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment. Cell Mol Immunol (2014). doi: 10.1038/cmi.2014.59.
39. Arikawa, K. et al. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G proteincoupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278, 32841-32851 (2003).
40. Chen, S. et al. [Senescent endothelial dysfunctions were mediated by S1P2 receptor in cultured human umbilical vein endothelial cells]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37, 1239-1245 (2012).
41. Olson, M. F., Ashworth, A. & Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270-1272 (1995).
42. Kolsch, V., Charest, P. G. & Firtel, R. A. The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci 121, 551-559 (2008).
43. Yang, L. et al. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-Associated angiogenesis. J Hepatol 59, 114-123 (2013).